ISMRM & SMRT Annual Meeting • 15-20 May 2021
SMRT Session | 14:00 - 16:00 | Moderators: Maureen Hood & Michael Salerno |
Myocardial T1, T2, T2* & ECV Mapping: The Clinical Promise
Wiphada Patricia Bandettini
• Parametric mapping tissue characterization has moved beyond the research realm and is now applicable within the clinical setting. Parametric mapping adds value to CMR, taking imaging beyond that of anatomy. Native T1, T2, and T2* offer non-contrast options to better characterize the myocardium. Extracellular volume fraction (ECV) helps to identify edema diffuse fibrosis. Edema, inflammation, fibrosis, and infiltration may be identified noninvasively by CMR. The tools of T1, T2, T2*, and ECV are ready for daily clinical use…if the appropriate QA and standards are followed. Parametric mapping offers improved diagnosis, management, and prognosis in the patient with cardiovascular disease.
|
||
Myocardial T1, T2, T2* & ECV Mapping: Challenges in the Field Video Permission Withheld
Alison Fletcher
|
||
Myocardial T1, T2, T2* & ECV Mapping: Upcoming Technical Solutions to Practical Problems
Jesse Hamilton
This presentation will cover recent technical advances in myocardial T1, T2, T2*, and ECV mapping. First, a review of conventional cardiac parameter mapping methods will be presented including MOLLI and SASHA (T1 mapping), T2-prepared gradient echo (T2 mapping), and multi-echo gradient echo (T2* mapping). Next, we will discuss recent technical innovations that address practical challenges in parameter mapping including motion correction, high-resolution 3D mapping, multiparametric techniques, free-running techniques, and deep learning for parameter mapping.
|
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.